Clinical Trials Directory

Trials / Completed

CompletedNCT03099954

Withings Pulse Wave Velocity and Blood Pressure Study

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Scripps Translational Science Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.

Detailed description

The study population will be an estimated 300 healthy adult subjects from the United States. This population will be approximately 150 men and 150 women. In order to obtain a relatively diverse age range of users (with varying levels of arterial stiffness), we hope to enroll participants across three age ranges entered in the Withings application by the user: 18-40 years, 41-60 years, and \> 60 years. These spots will be filled by those that satisfy the inclusion/exclusion criteria on a first come, first served basis.

Conditions

Timeline

Start date
2017-01-19
Primary completion
2017-08-01
Completion
2017-10-31
First posted
2017-04-04
Last updated
2018-03-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03099954. Inclusion in this directory is not an endorsement.

Withings Pulse Wave Velocity and Blood Pressure Study (NCT03099954) · Clinical Trials Directory